227 related articles for article (PubMed ID: 9876347)
21. Mature IGF-II prevents the formation of "big" IGF-II/IGFBP-2 complex in the human circulation.
Qiu Q; Yan X; Bell M; Di J; Tsang BK; Gruslin A
Growth Horm IGF Res; 2010 Apr; 20(2):110-7. PubMed ID: 19962924
[TBL] [Abstract][Full Text] [Related]
22. Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.
van Doorn J; Hoogerbrugge CM; Koster JG; Bloemen RJ; Hoekman K; Mudde AH; van Buul-Offers SC
Clin Chem; 2002 Oct; 48(10):1739-50. PubMed ID: 12324491
[TBL] [Abstract][Full Text] [Related]
23. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6.
Bond JJ; Meka S; Baxter RC
J Endocrinol; 2000 May; 165(2):253-60. PubMed ID: 10810289
[TBL] [Abstract][Full Text] [Related]
24. Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases.
de Groot JW; Rikhof B; van Doorn J; Bilo HJ; Alleman MA; Honkoop AH; van der Graaf WT
Endocr Relat Cancer; 2007 Dec; 14(4):979-93. PubMed ID: 18045950
[TBL] [Abstract][Full Text] [Related]
25. Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.
Jannin A; Espiard S; Benomar K; Do Cao C; Mycinski B; Porte H; D'Herbomez M; Penel N; Vantyghem MC
Ann Endocrinol (Paris); 2019 Feb; 80(1):21-25. PubMed ID: 29555080
[TBL] [Abstract][Full Text] [Related]
26. Severe hypoglycemia with "Big"-IGF-2 oversecretion by a giant phyllode tumor of the breast: a rare case of non-islet cell tumor-induced hypoglycemia (NICTH).
Renard E; Langbour-Remy C; Klein M; Le Bouc Y; Weryha G; Cuny T
Ann Endocrinol (Paris); 2012 Nov; 73(5):488-91. PubMed ID: 22867750
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.
Baxter RC; Holman SR; Corbould A; Stranks S; Ho PJ; Braund W
J Clin Endocrinol Metab; 1995 Sep; 80(9):2700-8. PubMed ID: 7545698
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic potential of miR-483 family for IGF-II producing non-islet cell tumor hypoglycemia.
Nagao M; Fukuda I; Asai A; Esguerra JLS; Hizuka N; Eliasson L; Sugihara H
Eur J Endocrinol; 2021 Jan; 184(1):41-49. PubMed ID: 33112286
[TBL] [Abstract][Full Text] [Related]
29. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
[TBL] [Abstract][Full Text] [Related]
30. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin.
Tally M; Eriksson U; Thorén M; Brismar K; Hall K
J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458
[TBL] [Abstract][Full Text] [Related]
31. Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia.
Zapf J
Horm Res; 1994; 42(1-2):20-6. PubMed ID: 7525443
[TBL] [Abstract][Full Text] [Related]
32. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
Zapf J; Futo E; Peter M; Froesch ER
J Clin Invest; 1992 Dec; 90(6):2574-84. PubMed ID: 1281841
[TBL] [Abstract][Full Text] [Related]
33. A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
Miraki-Moud F; Grossman AB; Besser M; Monson JP; Camacho-Hübner C
J Clin Endocrinol Metab; 2005 Jul; 90(7):3819-23. PubMed ID: 15840753
[TBL] [Abstract][Full Text] [Related]
34. A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II.
Hino N; Nakagawa Y; Ikushima Y; Yoshida M; Tsuyuguchi M
Breast Cancer; 2010 Apr; 17(2):142-5. PubMed ID: 19259766
[TBL] [Abstract][Full Text] [Related]
35. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
Daughaday WH; Kapadia M
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6778-82. PubMed ID: 2771956
[TBL] [Abstract][Full Text] [Related]
36. Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia.
Teale JD; Marks V
Clin Endocrinol (Oxf); 1990 Jul; 33(1):87-98. PubMed ID: 2205424
[TBL] [Abstract][Full Text] [Related]
37. Big insulin-like growth factor II-producing hepatocellular carcinoma associated with hypoglycemia.
Ishida S; Noda M; Kuzuya N; Kubo F; Yamada S; Yamanaka T; Isozaki O; Hizuka N; Kanazawa Y
Intern Med; 1995 Dec; 34(12):1201-6. PubMed ID: 8929651
[TBL] [Abstract][Full Text] [Related]
38. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia.
Daughaday WH; Trivedi B
J Clin Endocrinol Metab; 1992 Jul; 75(1):110-5. PubMed ID: 1618998
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K
Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583
[TBL] [Abstract][Full Text] [Related]
40. Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis.
Khosla S; Ballard FJ; Conover CA
J Clin Endocrinol Metab; 2002 Aug; 87(8):3867-70. PubMed ID: 12161524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
